This News Feed is administered on behalf of The Society of Cancer Management, a non-profit organisation supporting research that aims to increase the effectiveness of cancer treatment and the life-expectancy of patients. It’s objectives are to provide news and information on current developments in cancer disease management in order to raise public awareness of palliative care issues. The Society promotes research that assesses the short and long-term side-effects of radiation, alternative therapies and chemotherapeutic drugs; patient welfare; treatment associated microbial infections; metastasis and long-term physiological damage to organs and systems.
One problem encountered through compiling a similar news feed, over the last few years, has been a lack of press releases from UK research institutes and in managing infection during treatment. If you know of a good news source for these missing items please leave details.
Life After Cancer Treatment: A useful publication full of helpful advise by the National Cancer Institute (pdf)
Although the success of treating cancers has improved over time, European survival rates still lag behind that of the United States, Canada, Japan and Australia (Coleman et al., 2008). In Britain, the overall survival rate in 2007 was still under 50%. Variation in International survival rates have been mainly attributed to differences in access to diagnostic and treatment services. There are also racial variations in survival; with black cancer patients in the US having a lower rate of survival than their white counterparts. The specific reasons for this are unknown. It’s thought that a number of factors are involved including racial differences in tumour biology, stage at diagnosis, access to health care, or compliance with treatment. It is apparent that similar drugs and therapies are used to treat cancers world-wide and therefore other factors in the treatment process may lead to improved survival rates. For instance, this could simply be by improving nutrition in patients undergoing chemotherapy or reducing hospital acquired infections. There is a need to establish where and how improvements can be made by assessing all factors in the treatment process and striving to improve survival outcome.
For further information see Coleman et al (2008). Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol., 9, 730-56.
Many thanks for reading the blog and for taking an interest.